INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.58B / 21S · 3 late79 trades$24.55M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
43
SM
Sabag MarkSee "Remarks"
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Open-market sale
SELL$1.93M
46.0K sh
Nov 5, 2026Nov 6, 2026
Page 2 of 1649
← PrevNext →
traded Nov 5, 2026
+1d
SEC Form 4

Evidence

43
WJ
White Matthew JChief Financial Officer
LINLINDE PLC
Open-market sale
SELL$8.75M
16.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

43
OP
O'Hara Kevin PExecutive Vice President
HSTMHEALTHSTREAM INC
Open-market sale
SELL$124K
4,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

43
TD
Taylor Tate DeborahDirector
HSTMHEALTHSTREAM INC
Open-market sale
SELL$106K
3,281 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

42
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.14M
1,215 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

41
CB
Crowl BenChief Lending Officer, EVP
FSBWFS Bancorp, Inc.
Open-market sale
SELL$236K
5,399 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

41
SK
Stillwell KennethCOO, CFO
PEGAPEGASYSTEMS INC
Open-market sale
SELL$578K
16.3K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

41
KD
Kinder Richard DDirector, Executive Chairman, 10% Owner
KMIKINDER MORGAN, INC.
Open-market purchase
BUY$14.99M
500.0K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

41
KO
Koren OferCFO
GLBEGlobal-E Online Ltd.
Open-market sale
SELL$550K
12.5K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

41
BA
Baker Bros. Advisors LpDirector, 10% Owner
KODKodiak Sciences Inc.
Open-market purchase
BUY$14.97M
151.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

41
HB
Hoffman Michael BDirector
ANVSAnnovis Bio, Inc.
Open-market purchase
BUY—
5.00M sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$6.05M
18.3K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
RA
Rey David ADirector
FICOFAIR ISAAC CORP
Open-market purchase
BUY$7,367
8 sh
Sep 22, 2026Nov 6, 2026
traded Sep 22, 2026
+45dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$8.86M
26.5K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
CA
Capuano AnthonyDirector, President & CEO
MARMARRIOTT INTERNATIONAL INC /MD/
Open-market sale
SELL$1.13M
2,710 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
BD
Bergwerk DovInterim Cheif Legal Officer
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Open-market sale
SELL$365K
8,755 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
CA
Capuano AnthonyDirector, President & CEO
MARMARRIOTT INTERNATIONAL INC /MD/
Open-market sale
SELL$2.38M
5,605 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
KN
Klein NirDirector, Chief Executive Officer
SYNXSilynxcom Ltd.
Open-market purchase
BUY$9,807
10.0K sh
Nov 3, 2026Nov 6, 2026
traded Nov 3, 2026
+3dSEC Form 4

Evidence

40
CA
Capuano AnthonyDirector, President & CEO
MARMARRIOTT INTERNATIONAL INC /MD/
Open-market sale
SELL$1.53M
3,612 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$1.92M
5,870 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
FA
Fletcher Jeremy AdamEVP & CFO
ORLYO REILLY AUTOMOTIVE INC
Open-market sale
SELL$988K
10.6K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$4.96M
15.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
CA
Capuano AnthonyDirector, President & CEO
MARMARRIOTT INTERNATIONAL INC /MD/
Open-market sale
SELL$1.41M
3,364 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
ET
Elsener William ThomasEVP, Reservoir Engineering
MTDRMatador Resources Co
Open-market purchase
BUY$46K
900 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$3.87M
11.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$3.87M
11.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
BC
Baker James CDirector, President
KYNKayne Anderson Energy Infrastructure Fund, Inc.
Open-market purchase
BUY$331K
25.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

40
SJ
Schlosser Michael JEVP and Chief Clinical Officer
HCAHCA Healthcare, Inc.
Open-market sale
SELL$594K
1,200 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$1.29M
3,978 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$8.30M
25.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$2.11M
6,577 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$3.58M
10.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$2.97M
8,934 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
TJ
Treff Douglas JDirector
CROXCrocs, Inc.
Open-market sale
SELL$1.71M
10.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$412K
439 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$499K
529 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$541K
575 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
SC
Seidman Becker CarynDirector, Chief Executive Officer, 10% Owner
YOUClear Secure, Inc.
Open-market sale · 10b5-1 plan
SELL$10.00M
165.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$925K
982 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
HN
Hunn Laurence NeilDirector, President and CEO
ROPROPER TECHNOLOGIES INC
Open-market sale
SELL$1.54M
3,120 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence